Veröffentlichungen

Buch

Clarenbach P, Beneš H. Das Restless-Legs-Syndrom. Bremen: Uni-Med-Verlag 2006.

Artikel in Handbüchern

Kohnen R, Beneš H. Studien mit Psychopharmaka. In Benkert O, Gründer G, Holsboer F. Handbuch der Psychopharmakologie. Heidelberg: Springer 2007, pp. 459-476.

Andere Buchbeiträge

Trenkwalder C, Beneš H, Hornyak M, Riemannn D, Stiasny-Kolster K, Winkelmann J. Restless Legs Syndrom (RLS) und Periodic Limb Movement Disorder (PLMD). In: Diener C (Ed.). Leitlinien für Diagnostik und Therapie in der Neurologie. Stuttgart: Thieme 2003, pp 58-62.

Benes H, Kohnen R. Assessment of Restless Legs Syndrome feature with standardized methods. In: Hening WA, Allen RP, Chokroverty S, Earley CJ (Eds.). Restless Legs Syndrome. Philadelphia: Saunders Elsevier, 2009. pp 150 – 160.

Allen RP, Benes H, Kohnen R. Restless Legs Syndrome Morbidity: Sleep and Quality of Life. In: Hening WA, Allen RP, Chokroverty S, Earley CJ (Eds.). Restless Legs Syndrome. Philadelphia: Saunders Elsevier, 2009. pp 284 – 292.

Veröffentlichte Manuskripte in “peer-reviewed“ Zeitschriften

Garcia-Borreguero D, Stillman P, Benes H, Buschmann H, Chaudhuri KR, Gonzalez Rodriguez VM, Hogl B, Kohnen R, Monti GC, Stiasny-Kolster K, Trenkwalder C, Williams AM, Zucconi M. Algorithms for the diagnosis and treatment of restless legs syndrome in primary care. BMC Neurol. 2011 Feb 27;11(1):28. [Epub ahead of print].

Benes H, Mattern W, Peglau I, Dreykluft T, Bergmann L, Hansen C, Kohnen R, Banik N, Schoen SW, Hornyak M on behalf of the ROAD-RLS study group. Ropinirole improves depressive symptoms and restless legs syndrome severity in RLS patients: a multicentre, randomised, double-blind, placebo-controlled study. J Neurol. 2010 Dec 28. [Epub ahead of print]

Högl B, Oertel WH, Stiasny-Kolster K, Geisler P, Benes H, Garcia-Borreguero D, Trenkwalder C, Poewe W, Schollmayer E, Kohnen R. Treatment of moderate to severe restless legs syndrome: 2-year safety and efficacy of rotigotine transdermal patch. BMC Neurol. 2010 Sep 28;10(1):86. [Epub: http://www.biomedcentral.com/1471-2377/10/86]

Garcia-Borreguero D, Allen R, Kohnen R, Benes H, Winkelman J, Högl B, Ferini-Strambi L, Zucconi M, Trenkwalder C. Loss of response during long-term treatment of restless legs syndrome: Guidelines approved by the International Restless Legs Syndrome Study Group for use in clinical trials. Sleep Med. 2010;11:956-957.

Oertel WH, Benes H, Garcia-Borreguero D, Högl B, Poewe W, Montagna P, Ferini-Strambi L, Sixel-Döring F, Trenkwalder C, Partinen M, Saletu B, Polo O, Fichtner A, Schollmayer E, Kohnen R, Cassel W, Penzel T, Stiasny-Kolster K. Rotigotine transdermal patch in moderate to severe idiopathic restless legs syndrome: A randomized, placebo-controlled polysomnographic study. Sleep Med. 2010;11:848-856. [Epub ahead of print 2010 Sep 1].

Högl B, García-Borreguero D, Kohnen R, Ferini-Strambi L, Hadjigeorgiou G, Hornyak M, de Weerd A, Happe S, Stiasny-Kolster K, Gschliesser V, Egatz R, Frauscher B, Benes H, Trenkwalder C, Hening WA, Allen RP. Progressive development of augmentation during long-term treatment with levodopa in restless legs syndrome: results of a prospective multi-center study. J Neurol. 2010; 257:230-237. [Epub ahead of print 2009 Sep 11]

Hornyak M, Benes H, Eisensehr I, Haan J, Kassubek J, Peglau I, Stiasny-Kolster K, Trenkwalder C. [Depression in restless legs syndrome. Pathogenesis, assessment, and implications for treatment]. Nervenarzt. 2009 Oct;80(10):1160-6, 1164-6, 1168.

Benes H, Kohnen R. The Restless Legs Syndrome Diagnostic Index (RLS-DI). Validation of an Algorithm for the Diagnosis of the Restless Legs Syndrome (RLS). Sleep Med 2009; 10:515-523. DOI: 10.1016/j.sleep.2008.06.006 [E-pub ahead of print].

Benes H, von Eye A, Kohnen R. Empirical evaluation of the accuracy of diagnostic criteria for the Restless Legs Syndrome. Sleep Med 2009; 10:524-530. DOI:10.1016/j.sleep.2008.06.007 [E-pub ahead of print].

Oertel WH, Beneš H, Garcia-Borreguero D, Geisler P, Högl B, Trenkwalder C, Tacken I, Schollmayer E, Kohnen R, Stiasny-Kolster K on behalf of the Rotigotine SP710 Study Group. One year open-label safety and efficacy trial with rotigotine transdermal patch in moderate to severe idiopathic restless legs syndrome. Sleep Med 2008; 9:865-873. DOI:10.1016/jsleep.2008.04.012 [e-pub ahead of print].

Trenkwalder C, Beneš H, Poewe W, Oertel WH, Garcia-Borreguero D, de Weerd AW, Ferini-Strambi L, Montagna P, Odin P, Stiasny-Kolster K, Högl B, Chaudhuri KR, Partinen M, Schollseptemberer E, Kohnen R, on behalf of the SP790 Study Group Successful use of low-dose rotigotine in RLS - a randomised controlled large-scale trial with rotigotine transdermal patch. Lancet Neurology 2008;7:595-604.

Trenkwalder C, Högl B, Benes H, Kohnen R. Augmentation in restless legs syndrome is associated with low ferritin. Sleep Med. 2008:9:572-574 [Epub ahead of print: 07 Oct 2007]

García-Borreguero D, Allen RP, Beneš H, Earley C, Happe S, Högl B, Kohnen R, Paulus W, Rye D, Winkelmann J. Augmentation as a treatment complication of restless legs syndrome: Concept and management. Mov Disord. 2007; 22 (Suppl.18):S485-S494.

Beneš H, Walters AS, Allen RP, Hening WA, Kohnen R. Definition of restless legs syndrome, how to diagnose it, and how to differentiate it from RLS mimics. Mov Disord. 2007 22 (Suppl.18): S401-S408.

Oertel WH, Beneš H, Garcia-Borreguero D, Geisler P, Högl B, Saletu B, Trenkwalder C, Sommerville KW, Schollseptemberer E, Kohnen R, Stiasny-Kolster K; On behalf of the Rotigotine SP 709 Study Group. Efficacy of rotigotine transdermal system in severe restless legs syndrome: A randomized, double-blind, placebo-controlled, six-week dose-finding trial in Europe. Sleep Med. 9(2008) : S228-239

Kohnen R, Allen RP, Benes H, Garcia-Borreguero D, Hening WA, Stiasny-Kolster K, Zucconi M. Assessment of restless legs syndrome-Methodological approaches for use in practice and clinical trials. Mov Disord. 2007; 22 (Suppl.18):S485-S494.

Trenkwalder C, Kohnen R, Allen RP, Beneš H, Ferini-Strambi L, Garcia-Borreguero D, Hadjigeorgiou GM, Happe S, Högl B, Hornyak M, Klein C, Nass A, Montagna P, Oertel WH, O'keeffe S, Paulus W, Poewe W, Provini F, Pramstaller PP, Sieminski M, Sonka K, Stiasny-Kolster K, de Weerd A, Wetter TC, Winkelmann J, Zucconi M. Clinical trials in restless legs syndrome-Recommendations of the European RLS Study Group (EURLSSG). Movement Disorders, 2007;22 (Suppl.18), S495-S504.

Oertel WH, Trenkwalder C, Zucconi M, Beneš H, Garcia-Borreguero D, Bassetti C, Partinen M, Ferini-Strambi L, Stiasny-Kolster K. State of the art in restless legs syndrome therapy: Practice recommendations for treating restless legs syndrome. Movement Disorders, 2007;22 (Suppl.18), S466-S475.

Trenkwalder C, Beneš H, Grote L, Happe S, Hogl B, Mathis J, Saletu-Zyhlarz GM, Kohnen R. Cabergoline compared to levodopa in the treatment of patients with severe restless legs syndrome: Results from a multi-center, randomized, active controlled trial. Mov Disord. 2007; 22:696-703

Oertel WH, Beneš H, Bodenschatz R, Peglau I, Warmuth R, Happe S, Geisler P, Cassel W, Leroux M, Kohnen R, Stiasny-Kolster K. Efficacy of cabergoline in restless legs syndrome: A placebo-controlled, 5-week, polysomnographic, double-blind, randomized, multicenter, study with polysomnography and RLS rating scales (CATOR). Neurology 2006;67:1040-1046

Beneš H. Transdermal Lisuride: First Efficacy and Tolerability Study in Patients with Severe Restless Legs Syndrome. Sleep Med. 2006;7:31-35.

Beneš H, Deissler A, Rodenbeck A, Engfer A, Kohnen R. Lisuride treatment of Restless Legs Syndrome: first studies with monotherapy in de novo patients and in combination with levodopa in advanced disease. J Neural Transm. 2006;113:87-92.

Stiasny-Kolster K, Beneš H, Peglau I, Hornyak M, Holinka B, Wessel K, Emser W, Leroux M, Kohnen R, Oertel WH. Effective cabergoline treatment in idiopathic restless legs syndrome. Neurology. 2004;63:2272-2279.

Horowski R, Beneš H, Fuxe K. Striatal plasticity and motor learning - importance of circadian rhythms, sleep stages and dreaming. Parkinsonism Relat Disord. 2004;10:315-317.

Beneš H, Heinrich CR, Überall M, Kohnen R. Long-term safety and efficacy of cabergoline for the treatment of idiopathic Restless Legs Syndrome: Results from an open-label six-month clinical trial. Sleep 2004; 27:674-682.

Beneš H, Kurella B, Kummer J, Kazenwadel J, Selzer R, Kohnen R. Rapid onset of action of levodopa in restless legs syndrome: A double-blind, randomised, multi-center, crossover trial. Sleep 1999;22:1073-1081.

Veröffentlichte Manuskripte in anderen Zeitschriften

Hornyak M, Benes H, Eisensehr I, Haan J, Kassubek J, Peglau I, Stiasny-Kolster K, Trenkwalder C Depression in restless legs syndrome: Pathogenesis, assessment, and implications for treatment. Nervenarzt. 2009 Apr 11. [Epub ahead of print]

Happe S, Benes H, Hornyak M, Kotterba S, Septemberer G, Stiasny-Kolster K und Mitglieder der AG “Motorik und Schlaf” der Deutschen Gesellschaft für Schlafforschung und Schlafmedizin. Begutachtung des Restless Legs Syndroms – eine Konsensusempfehlung. Somnologie 2006;10:206-209.

Benes H. Was gibt es Neues zum Restless Legs Syndrom? Psychoneuro 2004; 30:438-443.

Beneš H. Idiopathisches Restless-Legs-Syndrom: Behandlung mit Lisurid. Nervenheilkunde 2001; 20:119-122.

Beneš H, Hening WA, Högl B, Peglau I, Schuler P, Stiasny K, Trenkwalder C, Voderholzer U. Restless Legs Syndrom. Richtlinien für Diagnostik und Therapie. MMW Fortschr Med. 2001; 143(45):50-51.

Beneš H. Das Restless Legs Syndrom: Klinisches Bild, funktionelle Auswirkungen und Begutachtung. Der Medizinische Sachverständige 2000;96:120-124.